126 related articles for article (PubMed ID: 2121016)
21. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis.
Oler A; Whooley MA; Oler J; Grady D
JAMA; 1996 Sep; 276(10):811-5. PubMed ID: 8769591
[TBL] [Abstract][Full Text] [Related]
22. Aspirin, heparin, or both to treat acute unstable angina.
Théroux P; Ouimet H; McCans J; Latour JG; Joly P; Lévy G; Pelletier E; Juneau M; Stasiak J; deGuise P
N Engl J Med; 1988 Oct; 319(17):1105-11. PubMed ID: 3050522
[TBL] [Abstract][Full Text] [Related]
23. Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina.
Vejar M; Hackett D; Brunelli C; Spallarossa P; Ianetti M; Galassi AR; Lipkin D; Caponnetto S; Patrono C; Maseri A
Circulation; 1990 Jan; 81(1 Suppl):I4-11; discussion I22-3. PubMed ID: 2403867
[TBL] [Abstract][Full Text] [Related]
24. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial. Organisation to Assess Strategies for Ischemic Syndromes (OASIS-2) Investigators.
Lancet; 1999 Feb; 353(9151):429-38. PubMed ID: 9989712
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
[TBL] [Abstract][Full Text] [Related]
26. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.
Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
N Engl J Med; 1998 May; 338(21):1498-505. PubMed ID: 9599104
[TBL] [Abstract][Full Text] [Related]
27. Tissue plasminogen activator using a rapid-infusion low-dose regimen for unstable angina.
Chaudhary H; Crozier I; Hamer A; Foy S; Shirlaw T; Ikram H
Am J Cardiol; 1992 Jan; 69(3):173-5. PubMed ID: 1731454
[TBL] [Abstract][Full Text] [Related]
28. Reactivation of unstable angina after the discontinuation of heparin.
Théroux P; Waters D; Lam J; Juneau M; McCans J
N Engl J Med; 1992 Jul; 327(3):141-5. PubMed ID: 1608405
[TBL] [Abstract][Full Text] [Related]
29. Thrombolysis with recombinant human tissue-type plasminogen activator during instability in coronary artery disease: effect on myocardial ischemia and need for coronary revascularization. TRIC Study Group.
Karlsson JE; Berglund U; Björkholm A; Ohlsson J; Swahn E; Wallentin L
Am Heart J; 1992 Dec; 124(6):1419-26. PubMed ID: 1462894
[TBL] [Abstract][Full Text] [Related]
30. Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial.
Yusuf S
Am J Cardiol; 1999 Sep; 84(5A):20M-25M. PubMed ID: 10505539
[TBL] [Abstract][Full Text] [Related]
31. Randomized trial of thrombolysis versus heparin in unstable angina.
Schreiber TL; Rizik D; White C; Sharma GV; Cowley M; Macina G; Reddy PS; Kantounis L; Timmis GC; Margulis A
Circulation; 1992 Nov; 86(5):1407-14. PubMed ID: 1423953
[TBL] [Abstract][Full Text] [Related]
32. Intracoronary recombinant tissue-type plasminogen activator in unstable angina: a pilot angiographic study.
DiSciascio G; Kohli RS; Goudreau E; Sabri N; Vetrovec GW
Am Heart J; 1991 Jul; 122(1 Pt 1):1-6. PubMed ID: 1905873
[TBL] [Abstract][Full Text] [Related]
33. Heparin induced increase of t-PA antigen plasma levels in patients with unstable angina: no evidence for clinical benefit of heparinization during the initial phase of treatment.
Huber K; Resch I; Rosc D; Probst P; Kaindl F; Binder BR
Thromb Res; 1989 Sep; 55(6):779-84. PubMed ID: 2506671
[TBL] [Abstract][Full Text] [Related]
34. Heparin and antiaggregating therapy in unstable angina.
Neri Serneri GG; Modesti PA; Abbate R; Gensini GF
Haemostasis; 1990; 20 Suppl 1():113-21. PubMed ID: 2083863
[TBL] [Abstract][Full Text] [Related]
35. Thrombolytic therapy for unstable angina pectoris: rationale and results.
Gold HK; Johns JA; Leinbach RC; Yasuda T; Collen D
J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):91B-95B. PubMed ID: 3117861
[TBL] [Abstract][Full Text] [Related]
36. Changes in wall motion in patients treated for unstable angina. A suggestion of the stunned and hibernating myocardium in humans. UNASEM Collaborative Study Group. Unstable Angina Study Using Eminase.
de Zwaan C; Bär FW; Dassen WR; Vermeer F; Wellens HJ
Chest; 1995 Oct; 108(4):903-11. PubMed ID: 7555159
[TBL] [Abstract][Full Text] [Related]
37. [Low-molecular-weight heparin in unstable angina pectoris].
Ocampo S; Solorio S; Rangel A; León FJ; Lepe L; Ayala F; Madrid R; Romero MA; Carrillo AM
Arch Inst Cardiol Mex; 1999; 69(3):222-7. PubMed ID: 10529855
[TBL] [Abstract][Full Text] [Related]
38. Additional molsidomine in refractory unstable angina pectoris.
Bertel O; Noll G
Cardiovasc Drugs Ther; 1988 May; 2(1):107-11. PubMed ID: 3154686
[TBL] [Abstract][Full Text] [Related]
39. Randomized trial comparing intravenous nitroglycerin and heparin for treatment of unstable angina secondary to restenosis after coronary artery angioplasty.
Doucet S; Malekianpour M; Théroux P; Bilodeau L; Côté G; de Guise P; Dupuis J; Joyal M; Gosselin G; Tanguay JF; Juneau M; Harel F; Nattel S; Tardif JC; Lespérance J
Circulation; 2000 Mar; 101(9):955-61. PubMed ID: 10704160
[TBL] [Abstract][Full Text] [Related]
40. Comparison of heparin therapy for < or = 48 hours to > 48 hours in unstable angina pectoris.
Klein LW; Wahid F; VandenBerg BJ; Parrillo JE; Calvin JE
Am J Cardiol; 1997 Feb; 79(3):259-63. PubMed ID: 9036741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
